Discovering metastasis genes that are clinically relevant and functionally important are critical for the development of novel therapeutics for high-risk breast
Raf kinase inhibitor protein (RKIP) was originally identified as a protein that bound membrane phospholipids and was named phosphatidylethanol-amine binding pro
Bone is one of the most preferential target sites for cancers such as breast, prostate and lung cancers to metastasize. Although the mechanism under-lying this